Max Healthcare Institute (543220) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
8 Jul, 2026Executive summary
Operationalized a new 303-bed hospital in Dwarka, South Delhi, under an O&M contract, with significant pre-launch hiring and marketing costs of INR 6 crores in Q1 FY25.
Announced a build-to-suit transaction for a 250+ bed hospital in Zirakpur, Mohali, Punjab, on a long-term lease, expected to be commissioned before FY 2028.
Lucknow and Nagpur hospitals, acquired at end Q4 last year, ramped up well, contributing INR 99 crores to revenue and INR 18 crores to operating EBITDA in Q1, with 21% and 64% year-on-year growth, respectively.
15th consecutive quarter of year-on-year growth, with network gross revenue at INR 2,028 crores, up 18% year-on-year and 7% quarter-on-quarter.
Appointment of Mr. Gautam Wadhwa as Director & Chief Business Officer effective August 5, 2024.
Financial highlights
Network operating EBITDA was INR 499 crores, net of INR 6 crores one-time pre-launch costs at Dwarka, up 14% year-on-year but down 1% quarter-on-quarter.
Profit after tax stood at INR 295 crores, compared to INR 291 crores in Q1 last year and INR 311 crores in the previous quarter.
Average occupancy increased to 77% from 74% year-on-year and 75% sequentially; ARPOB improved to INR 80,100, up 7% year-on-year and 3% quarter-on-quarter.
Free cash flow from operations was INR 258 crores, with INR 213 crores deployed towards capacity expansion and upgrades. Net cash position at INR 66 crores as of June 2024.
Existing units pre-tax ROCE was 33%; overall ROCE 25%.
Outlook and guidance
Substantial improvements expected during the year, especially as post-merger integration and infrastructure upgrades progress.
Oncology and surgical mix expansion in new hospitals expected to drive ARPOB and profitability higher in coming quarters.
New facilities (Nanavati, Smart, Mohali) expected to be operational within the next 6-12 months, with minimal pre-launch costs for brownfield expansions.
Focus on expanding international patient reach, enhancing local visibility, and strengthening medical capabilities at new hospitals.
Ongoing brownfield and greenfield expansions, targeting ~2X bed capacity in next 4-5 years.
Latest events from Max Healthcare Institute
- FY26 revenue rose 16% YoY to INR 10,538 crore, with 22% PAT growth and major capacity expansions.543220
Q4 25/268 Jul 2026 - Q2 FY26 delivered 21% revenue and 23% EBITDA growth, driven by expansion and digital gains.543220
Q2 25/268 Jul 2026 - FY25 revenue rose 26% YoY to INR 9,065 Cr, with robust EBITDA growth and major expansions.543220
Q4 24/258 Jul 2026 - Q3 FY25 revenue rose 34% with strong EBITDA, major expansions, and Jaypee Healthcare acquisition.543220
Q3 24/258 Jul 2026 - Q3 FY26 delivered strong growth, with expansion, digital gains, and regulatory impacts shaping outlook.543220
Q3 25/2612 Apr 2026 - Strong revenue and EBITDA growth, major acquisitions, and expansion marked the quarter.543220
Q2 24/2516 Jan 2026 - Revenue up 27% YoY, EBITDA up 23%, and PAT up 17% amid robust expansion and digital growth.543220
Q1 25/2623 Nov 2025